Nippon India Nifty Pharma ETF
Holdings
22
Concentrated
Top 10 weight
79%
Concentration
Strategy
Passive
Portfolio style
Equity
100%
Asset allocation
Portfolio
1Sectors7Large positions99.8%Top: Pharmaceuticals & Biotechnology0.0%Cash
Market-cap allocation
Large cap55%
Mid cap37%
Small cap8%
Asset allocation
Equity100%
Top holdings
Sun Pharmaceutical Industries LimitedEQUITY21.3%
Divi's Laboratories LimitedEQUITY10.3%
Cipla LimitedEQUITY8.4%
Torrent Pharmaceuticals LimitedEQUITY7.6%
Laurus Labs LimitedEQUITY7.1%
Dr. Reddy's Laboratories LimitedEQUITY7.1%
Lupin LimitedEQUITY5.9%
Aurobindo Pharma LimitedEQUITY4.4%
Alkem Laboratories LimitedEQUITY3.4%
Glenmark Pharmaceuticals LimitedEQUITY3.4%
Sign in for free to unlock all 22 holdings →Portfolio insights
Portfolio read
- 100% equity.
- Large-cap exposure is 55%.
- Largest equity sector is Pharmaceuticals & Biotechnology at 99.8%.
Watchpoints
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 100%.
Generated from current fund metrics. Educational research only.
Peer comparison
Other funds in ETF.
Explore comparable funds →Sector exposure
Showing top sectors from the current portfolio.